| http://dbpedia.org/ontology/abstract
|
Arena Pharmaceuticals, Inc. is an American … Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease. In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials. In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash. In March 2022, it was announced the acquisition by Pfizer had been concluded. acquisition by Pfizer had been concluded.
|
| http://dbpedia.org/ontology/foundingYear
|
1997
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/ArenaLogo.jpg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Subsidiary +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.arenapharm.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
21470125
|
| http://dbpedia.org/ontology/wikiPageLength
|
9434
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1114710542
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Crohn%27s_disease +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:American_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:2022_mergers_and_acquisitions +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Subsidiary +
, http://dbpedia.org/resource/Lorcaserin +
, http://dbpedia.org/resource/Pfizer +
, http://dbpedia.org/resource/Ulcerative_colitis +
, http://dbpedia.org/resource/Category:Pfizer +
, http://dbpedia.org/resource/Nelotanserin +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1997 +
, http://dbpedia.org/resource/APD371 +
, http://dbpedia.org/resource/Etrasimod +
, http://dbpedia.org/resource/List_of_biotechnology_companies +
, http://dbpedia.org/resource/Thrombosis +
, http://dbpedia.org/resource/Pulmonary_Arterial_Hypertension +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
, http://dbpedia.org/resource/Category:1997_establishments_in_California +
, http://dbpedia.org/resource/Pulmonary_hypertension +
, http://dbpedia.org/resource/Taisho_Pharmaceutical_Co. +
, http://dbpedia.org/resource/Celgene +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Ozanimod +
, http://dbpedia.org/resource/U.S._Food_and_Drug_Administration +
, http://dbpedia.org/resource/G_protein-coupled_receptors +
, http://dbpedia.org/resource/Autoimmune_disease +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Diego +
, http://dbpedia.org/resource/Eli_Lilly_and_Company +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/San_Diego%2C_California +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
|
| http://dbpedia.org/property/assets
|
261M
|
| http://dbpedia.org/property/equity
|
98.6M
|
| http://dbpedia.org/property/founded
|
1997
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Dominic Behan, co-founder and senior scientist
, Jack Lief, co-founder
, Amit Munshi, CEO
, Kevin Lind, CFO
|
| http://dbpedia.org/property/locationCity
|
http://dbpedia.org/resource/San_Diego%2C_California +
|
| http://dbpedia.org/property/locationCountry
|
U.S.
|
| http://dbpedia.org/property/logo
|
ArenaLogo.jpg
|
| http://dbpedia.org/property/name
|
Arena Pharmaceuticals
|
| http://dbpedia.org/property/netIncome
|
-85.5M
|
| http://dbpedia.org/property/operatingIncome
|
-57M
|
| http://dbpedia.org/property/products
|
Belviq
|
| http://dbpedia.org/property/revenue
|
27.6M
|
| http://dbpedia.org/property/type
|
Subsidiary of Pfizer
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Url +
, http://dbpedia.org/resource/Template:Loss +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:Profit +
, http://dbpedia.org/resource/Template:As_of +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Diego +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:American_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:Pfizer +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:1997_establishments_in_California +
, http://dbpedia.org/resource/Category:2022_mergers_and_acquisitions +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.433329.c +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Arena_Pharmaceuticals?oldid=1114710542&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/ArenaLogo.jpg +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.arenapharm.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Arena_Pharmaceuticals +
|
| http://xmlns.com/foaf/0.1/name
|
Arena Pharmaceuticals
|
| owl:sameAs |
https://global.dbpedia.org/id/4SUUG +
, http://dbpedia.org/resource/Arena_Pharmaceuticals +
, http://rdf.freebase.com/ns/m.03p1j40 +
, http://yago-knowledge.org/resource/Arena_Pharmaceuticals +
, http://www.wikidata.org/entity/Q4788901 +
|
| rdf:type |
http://dbpedia.org/class/yago/WikicatCompaniesInTheNASDAQBiotechnologyIndex +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnNASDAQ +
, http://dbpedia.org/ontology/Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedStates +
, http://schema.org/Organization +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInSanDiego%2CCalifornia +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
|
| rdfs:comment |
Arena Pharmaceuticals, Inc. is an American … Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease. In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials. In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash. In March 2022, it was announced the acquisition by Pfizer hadas announced the acquisition by Pfizer had
|
| rdfs:label |
Arena Pharmaceuticals
|
